Skip to main content
. 2020 Feb 10;8(2):170–175. doi: 10.1016/j.ajur.2020.02.001

Table 3.

PMSA PET/CT Scan versus CT abdomen pelvis and bone scan in finding oligometastatic disease.

Oligometastatic disease ≤3 lesions Widespread disease >4 lesions
PSMA PET/CT, n (%) 143 (37.2) 63 (16.4)
CT and BS, n (%) 102 (26.6) 15 (3.9)

BS, bone scan; CT, computed tomography; PET/CT, positron emission tomography/computed tomography; PSMA, prostate-specific membrane antigen.